NCT03197792

Brief Summary

The investigators aim to evaluate the utility of portal vein pulsatility as a predictor of the composite outcome of persistent organ dysfunction plus death in patients undergoing elective or urgent pulmonary endarterectomy for thromboembolic pulmonary hypertension. The investigators' hypothesis is that the portal vein pulsatility fraction, measured using transesophageal echocardiography immediately after weaning of cardiopulmonary bypass, is proportional to the risk of developing subsequent end-organ dysfunction in the postoperative setting.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2017

Completed
5 days until next milestone

Study Start

First participant enrolled

May 26, 2017

Completed
28 days until next milestone

First Posted

Study publicly available on registry

June 23, 2017

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 24, 2018

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2019

Completed
Last Updated

April 24, 2019

Status Verified

April 1, 2019

Enrollment Period

12 months

First QC Date

May 21, 2017

Last Update Submit

April 23, 2019

Conditions

Keywords

Transesophageal ultrasoundTEEPortal vein pulsatilitySplenic vein pulsatilityVenous congestionStrainRight ventricular dysfunctionPulmonary hypertensionVenous hypertension

Outcome Measures

Primary Outcomes (1)

  • Persistent organ dysfunction plus death (POD + death) 7 days after surgery

    POD + death, defined as death or one of the following criterias (yes or no) present on the 7th postoperative day : (1) mechanical ventilation (excluding non-invasive ventilation) without breaks for more than 48 hours, (2) ongoing need for vasopressor therapy more than 2 hours per day (dopamine more than 5 mcg/kg/min, phenylephrine more than 50 mcg/min, norepinephrine, epinephrine, vasopressin), (3) ongoing need for mechanical circulatory support such as ECMO or IABP, and (4) continuous renal replacement therapy or new intermittent hemodialysis.

    On the morning of the 7th postoperative day

Study Arms (1)

Pulmonary endarterectomy patients

EXPERIMENTAL

All patients

Other: All patients

Interventions

TEE is performed before cardiopulmonary bypass (before the opening of the pericardium, if possible) and immediately after weaning from cardiopulmonary bypass and optimization of the hemodynamic status by the attending anesthesiologist. A detailed ultrasound examination including portal vein pulsatility, splenic vein pulsatility, right and left ventricular global longitudinal strain and right and left systolic and diastolic function is recorded. A measure of portal vein pulsatility using TTE is also recorded before the onset of general anesthesia and on the morning of the 7th postoperative day. On the 7th postoperative day, the investigators will evaluate for the presence of the primary outcome, POD + death.

Pulmonary endarterectomy patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years or older
  • Elective or urgent pulmonary endarterectomy

You may not qualify if:

  • absolute or relative contraindication to the use of transesophageal echocardiography,
  • hepatic cirrhosis,
  • portal vein thrombosis,
  • concomitant coronary artery bypass grafting,
  • patient refusal or unable to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hopital Marie Lannelongue

Le Plessis-Robinson, 92350, France

RECRUITING

Related Publications (5)

  • Hahn RT, Abraham T, Adams MS, Bruce CJ, Glas KE, Lang RM, Reeves ST, Shanewise JS, Siu SC, Stewart W, Picard MH; American Society of Echocardiography; Society of Cardiovascular Anesthesiologists. Guidelines for performing a comprehensive transesophageal echocardiographic examination: recommendations from the American Society of Echocardiography and the Society of Cardiovascular Anesthesiologists. Anesth Analg. 2014 Jan;118(1):21-68. doi: 10.1213/ANE.0000000000000016. No abstract available.

    PMID: 24356157BACKGROUND
  • Jenkins D. Pulmonary endarterectomy: the potentially curative treatment for patients with chronic thromboembolic pulmonary hypertension. Eur Respir Rev. 2015 Jun;24(136):263-71. doi: 10.1183/16000617.00000815.

    PMID: 26028638BACKGROUND
  • Dittrich HC, Chow LC, Nicod PH. Early improvement in left ventricular diastolic function after relief of chronic right ventricular pressure overload. Circulation. 1989 Oct;80(4):823-30. doi: 10.1161/01.cir.80.4.823.

    PMID: 2791245BACKGROUND
  • Olson N, Brown JP, Kahn AM, Auger WR, Madani MM, Waltman TJ, Blanchard DG. Left ventricular strain and strain rate by 2D speckle tracking in chronic thromboembolic pulmonary hypertension before and after pulmonary thromboendarterectomy. Cardiovasc Ultrasound. 2010 Sep 27;8:43. doi: 10.1186/1476-7120-8-43.

    PMID: 20875129BACKGROUND
  • Marston N, Brown JP, Olson N, Auger WR, Madani MM, Wong D, Raisinghani AB, DeMaria AN, Blanchard DG. Right ventricular strain before and after pulmonary thromboendarterectomy in patients with chronic thromboembolic pulmonary hypertension. Echocardiography. 2015 Jul;32(7):1115-21. doi: 10.1111/echo.12812. Epub 2014 Oct 18.

    PMID: 25327878BACKGROUND

MeSH Terms

Conditions

Hypertension, PulmonaryPulmonary EmbolismPostoperative ComplicationsHeart FailureHyperemiaSprains and StrainsVentricular Dysfunction, Right

Condition Hierarchy (Ancestors)

Lung DiseasesRespiratory Tract DiseasesHypertensionVascular DiseasesCardiovascular DiseasesEmbolismEmbolism and ThrombosisPathologic ProcessesPathological Conditions, Signs and SymptomsHeart DiseasesWounds and InjuriesVentricular Dysfunction

Study Officials

  • MOORE ALEX, Dr

    HOPITAL MARIE LANNELONGUE

    PRINCIPAL INVESTIGATOR

Central Study Contacts

TRAORE AMINATA, CEC

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
SCREENING
Intervention Model
SINGLE GROUP
Model Details: Patients with chronic post-embolic pulmonary hypertension eligible to pulmonary endarterectomy surgery will be evaluated for venous congestion and right ventricular failure after weaning of cardiopulmonary bypass, and followed until the 7th postoperative day for the development of postoperative organ dysfunction and/or death.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor of thoracic surgery

Study Record Dates

First Submitted

May 21, 2017

First Posted

June 23, 2017

Study Start

May 26, 2017

Primary Completion

May 24, 2018

Study Completion

May 24, 2019

Last Updated

April 24, 2019

Record last verified: 2019-04

Data Sharing

IPD Sharing
Will not share

Locations